Fibrocell Science, Inc. Deferred Tax Assets, Net of Valuation Allowance
Fibrocell Science, Inc. had Deferred Tax Assets, Net of Valuation Allowance of $2.84 million as of 2018-12-31, per its 10-K filed 2019-03-27.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance
us-gaap:DeferredTaxAssetsNet · last filed 2019-03-27
- 2018-12-31: Deferred Tax Assets, Net of Valuation Allowance $2.84M.
- 2017-12-31: Deferred Tax Assets, Net of Valuation Allowance $2.82M.
- 2016-12-31: Deferred Tax Assets, Net of Valuation Allowance $4.26M.
- 2015-12-31: Deferred Tax Assets, Net of Valuation Allowance $1.76M.
| Period end | Deferred Tax Assets, Net of Valuation Allowance |
|---|---|
| 2018-12-31 | $2.84M 10-K · filed 2019-03-27 |
| 2017-12-31 | $2.82M 10-K · filed 2019-03-27 |
| 2016-12-31 | $4.26M 10-K · filed 2018-03-19 |
| 2015-12-31 | $1.76M 10-K · filed 2017-03-09 |
| 2014-12-31 | $2.00M 10-K · filed 2016-03-10 |
| 2013-12-31 | $2.25M 10-K · filed 2016-03-10 |
| 2012-12-31 | $2.28M 10-K · filed 2015-03-13 |
| 2011-12-31 | $2.28M 10-K · filed 2013-04-01 |